EGX: SIPC Statistics

Total Valuation

Sabaa International Company for Pharmaceutical and Chemical Industry has a market cap or net worth of EGP 347.50 million. The enterprise value is 379.40 million.

Market Cap	347.50M
Enterprise Value	379.40M

Important Dates

The next estimated earnings date is Saturday, March 1, 2025.

Earnings Date	Mar 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Sabaa International Company for Pharmaceutical and Chemical Industry has 250.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	250.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-1.00%
Owned by Insiders (%)	79.23%
Owned by Institutions (%)	n/a
Float	51.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.33
PB Ratio	3.34
P/TBV Ratio	3.34
P/FCF Ratio	40.84
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 248.60, with an EV/FCF ratio of 44.59.

EV / Earnings	-44.09
EV / Sales	24.38
EV / EBITDA	248.60
EV / EBIT	n/a
EV / FCF	44.59

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.31.

Current Ratio	1.46
Quick Ratio	0.21
Debt / Equity	0.31
Debt / EBITDA	21.24
Debt / FCF	3.81
Interest Coverage	-0.72

Financial Efficiency

Return on equity (ROE) is -7.98% and return on invested capital (ROIC) is -0.45%.

Return on Equity (ROE)	-7.98%
Return on Assets (ROA)	-0.37%
Return on Capital (ROIC)	-0.45%
Revenue Per Employee	94,303
Profits Per Employee	-52,152
Employee Count	165
Asset Turnover	0.09
Inventory Turnover	0.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +74.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+74.84%
50-Day Moving Average	1.40
200-Day Moving Average	0.92
Relative Strength Index (RSI)	48.17
Average Volume (20 Days)	3,077,164

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sabaa International Company for Pharmaceutical and Chemical Industry had revenue of EGP 15.56 million and -8.61 million in losses. Loss per share was -0.03.

Revenue	15.56M
Gross Profit	5.48M
Operating Income	-996,885
Pretax Income	-8.08M
Net Income	-8.61M
EBITDA	1.50M
EBIT	-996,885
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 517,972 in cash and 32.42 million in debt, giving a net cash position of -31.90 million or -0.13 per share.

Cash & Cash Equivalents	517,972
Total Debt	32.42M
Net Cash	-31.90M
Net Cash Per Share	-0.13
Equity (Book Value)	103.95M
Book Value Per Share	0.42
Working Capital	19.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.63 million and capital expenditures -2.12 million, giving a free cash flow of 8.51 million.

Operating Cash Flow	10.63M
Capital Expenditures	-2.12M
Free Cash Flow	8.51M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 35.22%, with operating and profit margins of -6.41% and -55.13%.

Gross Margin	35.22%
Operating Margin	-6.41%
Pretax Margin	-51.93%
Profit Margin	-55.13%
EBITDA Margin	9.66%
EBIT Margin	-6.41%
FCF Margin	54.69%

Dividends & Yields

Sabaa International Company for Pharmaceutical and Chemical Industry does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.48%
FCF Yield	2.45%

Stock Splits

The last stock split was on November 8, 2022. It was a forward split with a ratio of 5.

Last Split Date	Nov 8, 2022
Split Type	Forward
Split Ratio	5

Scores

Sabaa International Company for Pharmaceutical and Chemical Industry has an Altman Z-Score of 1.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.99
Piotroski F-Score	n/a